Results of combined and sequential liver-kidney transplantation

Liver Transplantation

Volumn 9, Issue 10, 2003, Pages 1067-1078

  Becker, Thomas ^a   Nyibata, Miguel ^a   Lueck, Rainer ^a   Bektas, Hueseyin ^a   Demirci, Gülçin ^a   Lehner, Frank ^a   Tusch, Günter ^a   Strassburg, Christian ^a   Schwarz, Anke ^a   Klempnauer, Juergen ^a   Nashan, Bjoern ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BASILIXIMAB; CALCINEURIN INHIBITOR; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; INOLIMOMAB; INTERLEUKIN 2 RECEPTOR ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; ELECTIVE SURGERY; FEMALE; FOLLOW UP; GLOMERULONEPHRITIS; GRAFT REJECTION; HEALTH STATUS; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY POLYCYSTIC DISEASE; KIDNEY TRANSPLANTATION; LIVER CIRRHOSIS; LIVER FUNCTION; LIVER POLYCYSTIC DISEASE; LIVER TRANSPLANTATION; LONG TERM CARE; MALE; PALLIATIVE THERAPY; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; REOPERATION; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEPSIS; SURGICAL MORTALITY; SURGICAL TECHNIQUE; SURVIVAL TIME; TREATMENT INDICATION; TREATMENT OUTCOME; VIRUS INFECTION;

EID: 10744230935     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1053/jlts.2003.50210     Document Type: Article

References (58)

1. Smith CM, Davies DB, McBride MA. Liver transplantation in the United States: A report from the UNOS Liver Transplant Registry. Clin Transpl 1999:23-34.
2. Cecka JM. The UNOS renal transplant registry. Clin Transpl 2001:1-18.
3. Abramson O, Rosenthal P. Current status of pediatric liver transplantation. Clin Liver Dis 2000;4:533-552.
4. Rosen HR. Hepatitis B and C in the liver transplant recipient: Current understanding and treatment. Liver Transpl 2001; 7(suppl 1):S87-98.
5. Vanrenterghem YF. Impact of new immunosuppressive agents on late graft outcome. Kidney Int Suppl 1997;63:S81-83.
6. Klintmalm GB, Gonwa TA. Nephrotoxicity associated with cyclosporine and FK506. Liver Transpl Surg 1995;1(suppl 1):11-19.
7. Fisher NC, Nightingale PG, Gunson BK, Lipkin GW, Neuberger JM. Chronic renal failure after liver transplantation: A retrospective analysis. Transplantation 1998;66:59-66.
8. Crawford DH, Endre ZH, Axelsen RA, Lynch SV, Balderson GA, Strong RW, et al. Universal occurrence of glomerular abnormalities in patients receiving liver transplants. Am J Kidney Dis 1992;19:339-344.
9. Weir MR, Kirkman RL, Strom TB, Tilney NL. Liver disease in recipients of long-functioning renal allografts. Kidney Int 1985; 28:839-844.
10. Huang CC. Hepatitis in patients with end-stage renal disease. J Gastroenterol Hepatol 1997;12:S236-241.
11. Margreiter R, Kramar R, Huber C, Steiner E, Niederwieser D, Judmaier G, Vogel W. Combined liver and kidney transplantation. Lancet 1984;1(8385):1077-1078.
12. Fung J, Makowka L, Tzakis A, Klintmalm GB, Duquesnoy R, Gordon R, Todo S, et al. Combined liver-kidney transplantation: Analysis of patients with preformed lymphocytotoxic antibodies. Transplant Proc 1988;20(suppl 1):88-91.
13. Gonwa TA, Nery JR, Husberg BS, Klintmalm GB. Simultaneous liver and renal transplantation in man. Transplantation 1988;46:690-693.
14. Gil-Vernet S, Prieto C, Grino JM, Leiva O, Castelao AM, Algranati L, et al. Combined liver-kidney transplantation. Transplant Proc 1992;24:128-129.
15. Shaked A, Thompson M, Wilkinson AH, Nuesse B, el-Khoury GF, Rosenthal JT, et al. The role of combined liver/kidney transplantation in end-stage hepato-renal disease. Am Surg 1993;59:606-609.
16. Hiesse C, Samuel D, Bensadoun H, Blanchet P, Castaing D, Adam R, et al. Combined liver and kidney transplantation in patients with chronic nephritis associated with end-stage liver disease. Nephrol Dial Transplant 1995;10(suppl 6):129-133.
17. Larue JR, Hiesse C, Samuel D, Blanchet P, Bensadoun H, Benoit G, et al. Experience in one center of combined kidney and liver transplantation in 22 patients: Incidence of graft rejection and long-term graft outcome. Transplant Proc 1997;29:243-244.
18. Jeyarajah DR, McBride M, Klintmalm GB, Gonwa TA. Combined liver-kidney transplantation: What are the indications? Transplantation 1997;64:1091-1096.
19. Chui AK, De Leon C, Rao AR, Verran DJ, Pathania OP, McCaughan GW, Sheil AG. Single-center experience of combined liver and kidney transplantation. Transplant Proc 1998; 30:3256-3257.
20. Remuzzi G, Ruggenenti P, Codazzi D, Noris M, Caprioli J, Locatelli G, Gridelli B. Combined kidney and liver transplantation for familial haemolytic uraemic syndrome. Lancet 2002; 359:1671-1672.
21. Ross AS, Graeme-Cook F, Cosimi AB, Chung RT. Combined liver and kidney transplantation in a patient with sickle cell disease. Transplantation 2002;73:605-608.
22. Neumann UP, Lang M, Moldenhauer A, Langrehr JM, Glanemann M, Kahl A, et al. Significance of a T-lymphocytotoxic crossmatch in liver and combined liver-kidney transplantation. Transplantation 2001;71:1163-1168.
23. Van Thiel DH, Schade RR, Gavaler JS, Shaw BW Jr, Iwatsuki S, Starzl TE. Medical aspects of liver transplantation. Hepatology 1984;4(suppl):79S-83S.
24. Rasmussen A, Davies HF, Jamieson NV, Evans DB, Calne RY. Combined transplantation of liver and kidney from the same donor protects the kidney from rejection and improves kidney graft survival. Transplantation 1995;59:919-921.
25. Morrissey PE, Gordon F, Shaffer D, Madras PN, Silva P, Sahyoun AI, et al. Combined liver-kidney transplantation in patients with cirrhosis and renal failure: Effect of a positive cross-match and benefits of combined transplantation. Liver Transpl Surg 1998;4:363-369.
26. Katznelson S, Cecka JM. The liver neither protects the kidney from rejection nor improves kidney graft survival after combined liver and kidney transplantation from the same donor. Transplantation 1996;61:1403-1405.
27. Kliem V, Ringe B, Frei U, Pichlmayr R. Single-center experience of combined liver and kidney transplantation. Clin Transplant 1995;9:39-44.
28. Muller R, Gubernatis G, Farle M, Niehoff G, Klein H, Wittekind C, et al. Liver transplantation in HBs antigen (HBsAg) carriers. Prevention of hepatitis B virus (HBV) recurrence by passive immunization. J Hepatol 1991;13:90-96.
29. Wood RP, Ellis D, Starzl TE. The reversal of the hepatorenal syndrome in four pediatric patients after successful orthotopic liver transplantation. Ann Surg 1987;205:415-419.
30. Seu P, Wilkinson AH, Shaked A, Busuttil RW. The hepatorenal syndrome in liver transplant recipients. Am Surg 1991;57:806-809.
31. Gonwa TA, Klintmalm GB, Levy M, Jennings LS, Goldstein RM, Husberg BS. Impact of pretransplant renal function on survival after liver transplantation. Transplantation 1995;59:361-365.
32. Jeyarajah DR, Gonwa TA, McBride M, Testa G, Abbasoglu O, Husberg BS, et al. Hepatorenal syndrome: Combined liver kidney transplants versus isolated liver transplant. Transplantation 1997;64:1760-1765.
33. Pereira BJ. Hepatitis C virus infection in dialysis: A continuing problem. Artif Organs 1999;23:51-60.
34. Swenson K, Seu P, Kinkhabwala M, Maggard M, Martin P, Goss J, Busuttil R. Liver transplantation for adult polycystic liver disease. Hepatology 1998;28:412-415.
35. Jeyarajah DR, Gonwa TA, Testa G, Abbasoglu O, Goldstein R, Husberg BS, et al. Liver and kidney transplantation for polycystic disease. Transplantation 1998;66:529-532.
36. Klupp J, Bechstein WO, Lobeck H, Neuhaus P. [Orthotopic liver transplantation in therapy of advanced polycystic liver disease]. Chirurg 1996;67:515-521.
37. Rogers J, Bueno J, Shapiro R, Scantlebury V, Mazariegos G, Fung J, Reyes J. Results of simultaneous and sequential pediatric liver and kidney transplantation. Transplantation 2001;72: 1666-1670.
38. Nolkemper D, Kemper MJ, Burdelski M, Vaismann I, Rogiers X, Broelsch CE, et al. Long-term results of pre-emptive liver transplantation in primary hyperoxaluria type 1. Pediatr Transplant 2000;4:177-181.
39. Shapiro R, Weismann I, Mandel H, Eisenstein B, Ben-Ari Z, Bar-Nathan N, et al. Primary hyperoxaluria type 1: Improved outcome with timely liver transplantation: A single-center report of 36 children. Transplantation 2001;72:428-432.
40. Scheinman JI. Recent data on results of isolated kidney or combined kidney/liver transplantation in the USA for primary hyperoxaluria. J Nephrol 1998;(suppl 1):42-45.
41. Jamieson NV. The results of combined liver/kidney transplantation for primary hyperoxaluria (PH1) 1984-1997. The European PH1 transplant registry report. European PH1 Transplantation Study Group. J Nephrol 1998;(suppl 1):36-41.
42. Allen AR, Thompson EM, Williams G, Watts RW, Pusey CD. Selective renal transplantation in primary hyperoxaluria type 1. Am J Kidney Dis 1996;27:891-895.
43. Thervet E, Legendre C, Daudon M, Chretien Y, Mejean A, Jungers P, et al. Is there a place for isolated renal transplantation in the treatment of primary hyperoxaluria type 1? Experience from Paris. Nephrol Dial Transplant 1995;(suppl 8):38-41.
44. Gagnadoux MF, Lacaille F, Niaudet P, Revillon Y, Jouvet P, Jan D, et al. Long term results of liver-kidney transplantation in children with primary hyperoxaluria. Pediatr Nephrol 2001;16: 946-950.
45. Monico CG, Milliner DS. Combined liver-kidney and kidney-alone transplantation in primary hyperoxaluria. Liver Transpl 2001;7:954-963.
46. Shaw BW Jr. Exclusion criteria for liver transplant recipients. Transplant Proc 1989;21:3484-3486.
47. Rodeck B, Melter M, Kardorff R, Hoyer PF, Ringe B, Burdelski M, et al. Liver transplantation in children with chronic end stage liver disease: Factors influencing survival after transplantation. Transplantation 1996;62:1071-1076.
48. Selberg O, Bottcher J, Tusch G, Pichlmayr R, Henkel E, Muller MJ. Identification of high- and low-risk patients before liver transplantation: A prospective cohort study of nutritional and metabolic parameters in 150 patients. Hepatology 1997;25:652-657.
49. Singh N. The current management of infectious diseases in the liver transplant recipient. Clin Liver Dis 2000;4:657-673, ix.
50. Patel R. Infections in recipients of kidney transplants. Infect Dis Clin North Am 2001;15:901-952, xi.
51. Ruder H, Otto G, Schutgens RB, Querfeld U, Wanders RJ, Herzog KH, et al. Excessive urinary oxalate excretion after combined renal and hepatic transplantation for correction of hyperoxaluria type 1. Eur J Pediatr 1990;150:56-58.
52. Latta K, Jamieson NV, Scheinman JI, Scharer K, Bensman A, Cochat P, et al. Selection of transplantation procedures and perioperative management in primary hyperoxaluria type 1. Nephrol Dial Transplant 1995;(suppl 8):53-57.
53. Soravia C, Mentha G, Giostra E, Morel P, Rohner A. Surgery for adult polycystic liver disease. Surgery 1995;117:272-275.
54. Henne-Bruns D, Klomp HJ, Kremer B. Non-parasitic liver cysts and polycystic liver disease: Results of surgical treatment. Hepatogastroenterology 1993;40:1-5.
55. Gigot JF, Jadoul P, Que F, Van Beers BE, Etienne J, Horsmans Y, et al. Adult polycystic liver disease: Is fenestration the most adequate operation for long-term management? Ann Surg 1997; 225:286-294.
56. Pirenne J, Aerts R, Yoong K, Gunson B, Koshiba T, Fourneau I, et al. Liver transplantation for polycystic liver disease. Liver Transpl 2001;7:238-245.
57. Radermacher J, Ellis S, Haller H. Renal resistance index and progression of renal disease. Hypertension 2002;39:699-703.
58. Davis CL, Gonwa TA, Wilkinson AH. Identification of patients best suited for combined liver-kidney transplantation: Part II. Liver Transpl 2002;8:193-211.